For the month ended 30 April 2026, Kintor Pharmaceutical Limited (Kintor Pharma) reported no movements in either authorised or issued share capital, according to the submission filed with Hong Kong Exchanges and Clearing Limited on 6 May 2026.
Authorised Share Capital • The authorised share pool remained at 700.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to USD 70,000 in aggregate nominal value.
Issued Share Capital and Public Float • Outstanding issued shares stood unchanged at 498.66 million ordinary shares. • The company held no treasury shares during the period. • Kintor Pharma confirmed compliance with the Main Board’s minimum public-float requirement of 25% of issued shares.
Capital Instruments and Other Movements • The filing recorded no activity involving share options, warrants, convertible securities, Hong Kong depositary receipts or other equity arrangements during the month.
Regulatory Confirmations • The board affirmed that all listings, regulatory and statutory obligations were met, including receipt of all monies due and completion of requisite filings.
The unchanged capital structure underscores stability in Kintor Pharma’s equity base for April 2026, with full adherence to Hong Kong Listing Rules and public-float standards.
Comments